Napean Trading & Investment Co Singapore PTE Ltd Has $12.74 Million Holdings in Danaher Co. (NYSE:DHR)

Napean Trading & Investment Co Singapore PTE Ltd grew its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 52.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 55,497 shares of the conglomerate's stock after buying an additional 19,193 shares during the period. Danaher makes up 3.2% of Napean Trading & Investment Co Singapore PTE Ltd's holdings, making the stock its 11th biggest position. Napean Trading & Investment Co Singapore PTE Ltd's holdings in Danaher were worth $12,739,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Kentucky Retirement Systems Insurance Trust Fund grew its position in Danaher by 11.6% during the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock worth $4,874,000 after buying an additional 2,202 shares in the last quarter. ORG Partners LLC grew its holdings in shares of Danaher by 1,212.8% during the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock worth $636,000 after purchasing an additional 2,559 shares in the last quarter. Generate Investment Management Ltd bought a new position in shares of Danaher in the fourth quarter worth $8,044,000. Stifel Financial Corp raised its stake in Danaher by 1.3% in the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate's stock valued at $235,583,000 after purchasing an additional 11,216 shares in the last quarter. Finally, Compass Capital Management Inc. lifted its position in Danaher by 4.8% during the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock worth $54,615,000 after purchasing an additional 10,994 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Remove Ads

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company's stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 11.10% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently commented on DHR shares. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $310.00 to $300.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Raymond James restated a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Wells Fargo & Company reduced their target price on Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a report on Thursday, January 30th. Barclays lowered their price target on Danaher from $275.00 to $240.00 and set an "equal weight" rating for the company in a report on Thursday, January 30th. Finally, Bank of America upgraded Danaher from a "neutral" rating to a "buy" rating and set a $290.00 target price on the stock in a research report on Friday, December 13th. Five research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Danaher presently has an average rating of "Moderate Buy" and an average target price of $278.24.

Danaher Trading Down 2.1 %

Shares of DHR traded down $4.43 during trading hours on Friday, hitting $205.69. 2,388,883 shares of the stock were exchanged, compared to its average volume of 3,186,485. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The business has a 50-day moving average of $214.57 and a 200-day moving average of $236.90. The firm has a market capitalization of $147.01 billion, a P/E ratio of 38.96, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts' consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the company posted $2.09 earnings per share. On average, research analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, March 28th. This is a positive change from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. Danaher's payout ratio is 24.24%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.